November 24, 2025 · Form 4 insider transaction
LIN SUE-JEAN bought 7,220 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $54.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.